-
Predictive value of residual SYNTAX score for clinical outcomes after High-Risk Percutaneous Coronary Intervention (HR-PCI): Evidence from pooled analysis of prospective studies
Vasileios F. Panoulas, Javier Escaned, Jonathan Michael Hill, Edward James Baker, Stuart Mealing, Seth Bilazarian, +6 more
0citations -
Self-management app usage and expectations by patients with heart failure: results of a qualitative study2024 European Heart Journal article Health Professions Mobile Health and mHealth Applications Open access
Anne Neumann, Josiane JJ Boyne, Niveditha Daneeza Dinesh Kanna, Loreena Hill, Marguerite Murphy, Marlo Verket, +5 more
0citations -
Measuring quality of life in cardiovascular diseases: findings from a scoping review on the use and relevance of patient-reported outcomes2025 European Heart Journal article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life
B Steiner, A Neumann, Markus Schwertfeger, Marlo Verket, I Romero, Anne McNulty, +5 more
0citations -
Impact of oral semaglutide on cardiovascular risk factors in patients with type 2 diabetes and atherosclerotic cardiovascular disease and/or chronic kidney disease: a SOUL post hoc analysis
Sharon L. Mulvagh, John Eric Deanfield, Samuel Emerson, S E Inzucchi, Johannes F.E. Mann, Nikolaus Marx, +9 more
0citations -
Effect of plaque characteristics on ischemia by invasive fractional flow reserve in nonobstructive versus obstructive coronary artery disease: results from the CREDENCE trial
Umberto Gianni, Inge J. van den Hoogen, Alexander R. van Rosendael, A. Maxim Bax, Sara W. Tantawy, Hyuk‐Jae Chang, +9 more
0citations -
Biomarkers for detection of anthracycline-induced cardiomyopathy in childhood cancer survivors: a case-control study in the Dutch LATER cohort study
Jan M. Leerink, Elizabeth A. M. Feijen, Annelies M. C. Mavinkurve‐Groothuis, Wim J. E. Tissing, Marloes Louwerens, Marry M. van den Heuvel‐Eibrink, +9 more
0citations -
Association between use of beta-blockers and mortality/morbidity in patients with heart failure with reduced, midrange or preserved ejection fraction and advanced chronic kidney disease
Edouard L. Fu, Alicia Uijl, Friedo Wilhelm Dekker, Lars H. Lund, Gianluigi Savarese, Juan Jesús Carrero
0citations